Patients with a clinical diagnosis of dyskeratosis congenita (DKC), particularly those with TINF2 mutation associated DKC, should undergo routine CT and MRI examinations of the central nervous system (CNS). The gene discussed is TINF2; the disease is dyskeratosis congenita.